TSX: HSM     OTC: HSDT

Call us: +1 877-564-0008

investorBanner

Stock Quote - HSDT

*Delayed quote courtesy of Yahoo.

Stock Quote - HSM-T

*Delayed quote courtesy of Yahoo.

Investor FAQ

Helius Medical Technologies is traded on the Toronto Stock Exchange under the symbol (TSX: HSM) and on the OTCQB marketplace under the symbol (OTCQB: HSDT).

The Company started trading on the Canadian Securities Exchange on June 23, 2014, under the symbol “HSM”, began trading on the OTCQB marketplace on February 10, 2015, under the symbol “HSDT” and began trading on the Toronto Stock Exchange on April 18th, 2016, under the symbol “HSM”. The Company completed a plan of merger (the “Transaction“) on June 13, 2014, as announced on June 13, 2014, whereby the Company acquired 100% of the issued and outstanding common shares of NeuroHabilitation Corporation (“Neuro“).

Helius Medical Technologies currently has a market capitalization of $173.25 million with approximately 63 million shares outstanding and a $2.75 share price (63 million X $2.75 = $173.25 million). For daily updated shares outstanding and prices please visit stockwatch.com (CA: HSM, USA: HSDT).

The company is incorporated in Wyoming.

Helius Medical Technologies headquarters is located at 642 Newtown Yardley Road, Suite 100, Newtown, PA 18940.

Our fiscal year end is December 31.

Shares can be purchased through a stockbroker of your choice.

No, not at this time.

Currently the company does not offer a dividend or stock reinvestment plan.

The Helius annual report, interim report and other material can be downloaded from the Reports and Filings page.

To request any additional financial information, please fill out the form at our contact page.

You can register to receive updates from Helius by submitting your email address under “Sign Up for News” at the top of this page.

You must contact our transfer agent, Helen Chai, at Computershare (www.computershare.com). The company can look up your records and make any necessary adjustments. There is a fee involved for replacing lost certificates. The company’s address is 510 Burrard Street-3rd Floor, Vancouver, British Columbia, V6C 3B9, Canada.

You must send both your old and new addresses to our transfer agent, Helen Chai, (Helen.Chai@computershare.com) by mail. Each stockholder in question must sign the request for an address change.

BDO Canada LLP is Helius’ independent registered public accounting firm.

Helius Medical Technologies uses Kern Communication. Please submit PR inquiries to media@heliusmedical.com.